The latest happenings in the industry from the past month, all in one place.
Worldwide Clinical Trials, Inc. announced that Mike Mencer has joined the company as the EVP and General Manager of Worldwide’s Early Phase Services, focusing on the Bioanalysis Lab in Austin, Texas, and the Clinical Pharmacology Unit clinic in San Antonio, Texas.
Signant Health is proud to announce the appointment of Ian Jennings as Chief Commercial Officer.
Abond CRO announced that Susan Walker is a member of its Board of Directors.
CTI Clinical Trial and Consulting Services announced the promotions of Hadley Decker and Chris Kaas to Director of Global Training & Development and Director of Information Technology, respectively.
Almac Clinical Services announced its Just in Time Manufacturing processes have received GMP compliance certification from Ireland’s Health Products Regulatory Authority.
Signant Health is proud to announce that it has officially opened a new office facility in Blue Bell, Pennsylvania.
Spaulding Clinical Research announced that it has been awarded a five-year contract with the U.S. Food and Drug Administration Division of Applied Regulatory Science to conduct multiple clinical trials in various therapeutic areas of interest.
Clinerion partners their Patient Network Explorerwith iClusion’s Trial Eye platforms to boost the identification and recruitment of more patients into clinical trials.
Clinerion has also announced that it has gained ISO 27001:2013 certification.
PPD, Inc. has been named to Training magazine’s 2020 Training Top 125 list.
Novotech has been recognized by the Workplace Gender Equality Agency as a WGEA Employer of Choice for Gender Equality.
CROMSOURCE announced a milestone in digital management of its projects in cooperation with TECHORIZON-initiating the 1,000th trial to be managed within TheClinical digital environment.
Celerion celebrates 10 years of industry leadership providing early clinical research services to the biopharmaceutical industry.
TARGET PharmaSolutions Inc. announced the launch of its seventh observational cohort study, TARGET-ASTHMA.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.